Mateusz et al stated that graphite nanoparticles and graphene oxide nanoplatelets could reduce intracellular ROS‐induced angiogenesis via the downregulation of NF‐κB‐dependent proangiogenic cytokines including IL‐6, IL‐8, growth‐regulated oncogene α (GROα) and monocyte chemotactic protein 1 (MCP‐1) in a p53wt glioma cell line (U87); however, they had no effect in a p53mut cell line (U118)84 (Figure 3 and Table 1). The gene discussed is CCL2; the disease is central nervous system cancer.